SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Klabin S.A. (KLBAY) trades at a trailing P/E of 17.7, forward P/E of 2.0. Trailing earnings yield is 5.65%, forward earnings yield 51.02%. PEG 0.35 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (17.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.35); earnings yield beats bond yields (5.65%).
- Forward P/E 2.0 (down from trailing 17.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.35 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 5.65% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 51.02% as earnings recover.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — KLBAY
Valuation Multiples
P/E (TTM)17.7
Forward P/E2.0
PEG Ratio0.35
Forward PEG0.35
P/B Ratio0.00
P/S Ratio1.15
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.44
Forward EPS (Est.)$3.98
Book Value / Share$0.00
Revenue / Share$6.75
FCF / Share$0.00
Yields & Fair Value
Earnings Yield5.65%
Forward Earnings Yield51.02%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.72 |
$7.09B |
$2.48B |
35% |
| 2017 |
$1.02 |
$8.37B |
$532.17M |
6.4% |
| 2018 |
$0.26 |
$10.02B |
$137.46M |
1.4% |
| 2019 |
$0.26 |
$10.27B |
$675.83M |
6.6% |
| 2020 |
$-0.88 |
$11.95B |
$-2.39B |
-20% |
| 2021 |
$1.10 |
$16.48B |
$3.02B |
18.3% |
| 2022 |
$1.62 |
$20.03B |
$4.46B |
22.3% |
| 2023 |
$0.90 |
$18.02B |
$2.69B |
14.9% |
| 2024 |
$0.52 |
$19.65B |
$1.83B |
9.3% |
| 2025 |
$0.44 |
$20.7B |
$1.4B |
6.8% |
